Korea Investment Corp
WST icon

Korea Investment Corp’s West Pharmaceutical WST Stock Holding History

Korea Investment Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Sell
33,088
-32,915
-50% -$10.1M 0.02% 453
2026
Q1 		$16.5M Sell
66,003
-44,967
-41% -$11.2M 0.03% 402
2025
Q4 		$30.5M Buy
110,970
+54,873
+98% +$15M 0.06% 288
2025
Q3 		$14.7M Buy
56,097
+31,635
+129% +$7.69M 0.03% 428
2025
Q2 		$5.35M Sell
24,462
-500
-2% -$107K 0.01% 597
2025
Q1 		$5.59M Buy
24,962
+6,600
+36% +$1.82M 0.01% 605
2024
Q4 		$6.01M Sell
18,362
-1,900
-9% -$598K 0.01% 601
2024
Q3 		$6.08M Sell
20,262
-15,379
-43% -$4.71M 0.01% 557
2024
Q2 		$11.7M Sell
35,641
-3,547
-9% -$1.25M 0.03% 427
2024
Q1 		$15.5M Buy
39,188
+5,361
+16% +$1.98M 0.04% 383
2023
Q4 		$11.9M Sell
33,827
-4,241
-11% -$1.5M 0.03% 418
2023
Q3 		$14.3M Buy
38,068
+11,153
+41% +$4.31M 0.04% 369
2023
Q2 		$10.3M Buy
26,915
+2,742
+11% +$980K 0.03% 409
2023
Q1 		$8.38M Sell
24,173
-20,318
-46% -$5.94M 0.02% 442
2022
Q4 		$10.5M Buy
44,491
+881
+2% +$209K 0.03% 414
2022
Q3 		$10.7M Buy
43,610
+2,584
+6% +$787K 0.03% 408
2022
Q2 		$12.4M Buy
41,026
+1,326
+3% +$431K 0.04% 384
2022
Q1 		$16.3M Buy
39,700
+6,700
+20% +$2.62M 0.04% 357
2021
Q4 		$15.5M Sell
33,000
-6,200
-16% -$2.67M 0.04% 322
2021
Q3 		$16.6M Buy
39,200
+600
+2% +$253K 0.05% 281
2021
Q2 		$13.9M Buy
38,600
+6,300
+20% +$2.08M 0.04% 324
2021
Q1 		$9.1M Sell
32,300
-32,100
-50% -$9.19M 0.03% 394
2020
Q4 		$18.2M Buy
64,400
+24,900
+63% +$6.99M 0.05% 267
2020
Q3 		$10.9M Buy
39,500
+3,100
+9% +$820K 0.04% 328
2020
Q2 		$8.27M Buy
36,400
+17,800
+96% +$3.5M 0.03% 353
2020
Q1 		$2.83M Buy
+18,600
New +$2.86M 0.01% 505

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Korea Investment Corp's WST Position: Q2 2026 in Review

Korea Investment Corp reduced its West Pharmaceutical (WST) stake by 50% in Q2 2026, selling an estimated $10.1M and leaving 33,088 shares worth $11.9M. The position accounts for 0.02% of the portfolio, ranked #453.

Korea Investment Corp first reported a position in WST in Q1 2020 and has held it in 26 quarters since. The position peaked at $30.5M in Q4 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Korea Investment Corp held 33,088 shares of West Pharmaceutical worth $11.9M as of Q2 2026.
  • Korea Investment Corp sold 32,915 West Pharmaceutical shares in Q2 2026, an estimated $10.1M.
  • West Pharmaceutical made up 0.02% of Korea Investment Corp's portfolio in Q2 2026, its #453 holding.
  • Korea Investment Corp first reported a position in West Pharmaceutical in Q1 2020 and has held it in 26 quarters since.
  • Korea Investment Corp's West Pharmaceutical position peaked at $30.5M in Q4 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.